Quantification of intratumoral heterogeneity of HER2 status in breast cancer.

被引：0
|
作者：
Horii, Rie
Matsuura, Masaaki
Nitta, Hiro
Ito, Yoshinori
Ohno, Shinji
Iwase, Takuji
Akiyama, Futoshi
机构：
[1] Japanese Fdn Canc Res, Inst Canc, Dept Pathol, Tokyo, Japan
[2] Japanese Fdn Canc Res, Inst Canc, Div Canc Genom, Tokyo, Japan
[3] Teikyo Univ, Grad Sch, Tokyo, Japan
[4] Ventana Med Syst Inc, Tucson, AZ USA
[5] Japanese Fdn Canc Res, Canc Inst Hosp, Breast Oncol Ctr, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.1036
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1036
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Quantification of HER2 autoantibodies in the amplification phenomenon of HER2 in breast cancer
    Lauterlein, Jens-Jacob L.
    Petersen, Eva R. B.
    Olsen, Dorte Aa
    Ostergaard, Birthe
    Brandslund, Ivan
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (05) : 877 - 883
  • [32] Intratumoral and intertumoral heterogeneity of HER2 immunohistochemical expression in gastric cancer
    Zhang, He
    Wang, Yi
    Wang, Yanfeng
    Wu, Daoyuan
    Lin, Enguang
    Xia, Qingxin
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (11)
  • [33] Quantification of HER2/HER3 Dimerisation Status in Primary Invasive Breast Cancer
    Barros, F. F. T.
    Abdel-Fatah, T. M. A.
    Rakha, E. A.
    Chan, S.
    Green, A. R.
    Ellis, I. O.
    JOURNAL OF PATHOLOGY, 2012, 228 : S14 - S14
  • [34] HER2 Gene Protein Assay: A Robust Tool for Evaluating HER2 Status and Intratumoral Heterogeneity in Endometrial Cancers
    Shafi, Saba
    Nitta, Hiroaki
    Shah, Manan
    Challa, Bindu
    Parwani, Anil, V
    Li, Zaibo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 159 (05) : 464 - 473
  • [35] Resistance to HER2 targeted therapy in early breast cancer (EBC): The clinical management of intratumoral heterogeneity (ITH) in HER2 overexpressing EBC
    Argyriadis, A.
    Kalfoutzos, K.
    Khodaverdi, S.
    Braun, S.
    Jackisch, C.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (10) : E43 - E44
  • [36] HER2 Intratumoral Heterogeneity is Associated with Distal Metastasis in HER2-positive Breast Carcinoma
    Shen, Tiansheng
    Nitta, Hiro
    Parwani, Anil
    Li, Zaibo
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 258 - 260
  • [37] HER2 Intratumoral Heterogeneity is Associated with Distal Metastasis in HER2-positive Breast Carcinoma
    Shen, Tiansheng
    Nitta, Hiro
    Parwani, Anil
    Li, Zaibo
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 258 - 260
  • [38] Intratumoral heterogeneity of HER2/neu and topoisomerase IIα in breast cancer:: a case with clonal monosomy 17
    Corzo, C
    Tusquets, I
    Suarez, M
    Fabregat, X
    Salido, M
    Solé, F
    Corominas, JM
    CANCER GENETICS AND CYTOGENETICS, 2004, 154 (01) : 89 - 90
  • [39] Pathologic Features and Clinical Implications of Breast Cancer With HER2 Intratumoral Genetic Heterogeneity: An Institutional Review
    Muller, Kristen E.
    Marotti, Jonathan D.
    Tafe, Laura J.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2019, 152 (01) : 7 - 16
  • [40] Assessment of HER2 status in breast cancer
    Penault-Llorca, F
    Cayre, A
    BULLETIN DU CANCER, 2004, 91 : S211 - S215
12345